Amrize (NYSE:AMRZ – Free Report) had its price objective cut by Oppenheimer from $68.00 to $65.00 in a research note issued to investors on Tuesday morning,Benzinga reports. They currently have an outperform rating on the stock.
Several other research firms have also recently weighed in on AMRZ. Sanford C. Bernstein restated an “outperform” rating on shares of Amrize in a research report on Monday, June 22nd. Vertical Research upgraded Amrize from a “hold” rating to a “buy” rating and set a $70.00 price objective for the company in a research report on Friday, May 1st. Morgan Stanley set a $63.00 price objective on Amrize and gave the company an “overweight” rating in a research note on Monday, June 22nd. Weiss Ratings downgraded shares of Amrize from a “hold (c)” rating to a “hold (c-)” rating in a research note on Monday, July 13th. Finally, Royal Bank Of Canada lowered their price target on Amrize from $61.00 to $60.00 and set a “sector perform” rating for the company in a research report on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $62.79.
Get Our Latest Analysis on Amrize
Amrize Price Performance
Amrize (NYSE:AMRZ – Get Free Report) last announced its quarterly earnings results on Wednesday, April 29th. The company reported ($0.16) earnings per share for the quarter, missing the consensus estimate of ($0.14) by ($0.02). The company had revenue of $2.18 billion for the quarter. Amrize had a net margin of 9.70% and a return on equity of 9.84%. The company’s revenue was up 4.7% compared to the same quarter last year. As a group, equities research analysts forecast that Amrize will post 2.74 EPS for the current year.
Amrize Cuts Dividend
The company also recently declared a dividend, which was paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th were paid a $0.11 dividend. The ex-dividend date was Tuesday, May 12th. Amrize’s payout ratio is presently 21.05%.
Insider Activity
In other news, insider Nollaig Forrest bought 2,000 shares of the company’s stock in a transaction dated Friday, May 22nd. The shares were purchased at an average price of $50.25 per share, for a total transaction of $100,500.00. Following the completion of the purchase, the insider owned 20,139 shares in the company, valued at approximately $1,011,984.75. This represents a 11.03% increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Jan Philipp Jenisch purchased 21,417 shares of Amrize stock in a transaction that occurred on Friday, May 15th. The shares were purchased at an average cost of $49.67 per share, with a total value of $1,063,782.39. Following the transaction, the chief executive officer directly owned 1,724,999 shares of the company’s stock, valued at $85,680,700.33. This represents a 1.26% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last three months, insiders have bought 54,920 shares of company stock worth $2,717,429. Corporate insiders own 0.54% of the company’s stock.
Hedge Funds Weigh In On Amrize
Several hedge funds and other institutional investors have recently modified their holdings of AMRZ. MCF Advisors LLC bought a new position in shares of Amrize in the 4th quarter worth approximately $27,000. Basepoint Wealth LLC purchased a new position in shares of Amrize during the 4th quarter valued at $33,000. Laurel Wealth Advisors LLC bought a new position in Amrize in the 4th quarter worth $34,000. US Bancorp DE bought a new position in Amrize in the 3rd quarter worth $38,000. Finally, Itau Unibanco Holding S.A. increased its stake in Amrize by 150.0% in the 4th quarter. Itau Unibanco Holding S.A. now owns 750 shares of the company’s stock worth $41,000 after buying an additional 450 shares in the last quarter.
About Amrize
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
See Also
- Five stocks we like better than Amrize
- Confidence Is Back, But Earnings Show the Consumer Is Being Picky
- AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off
- 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative?
- 3 Photonics Companies Making Quantum Tech Possible
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
